There is limited information about the initiation of triple therapy (TT) in patients with chronic
obstructive pulmonary disease (COPD) in primary care. This was an observational …

Background Recent data from real world clinical practices on the use of Triple Therapy (TT)
in patients with COPD are scarce. Methods Observational population-based study with …

Introduction Real-world prescription pathways leading to triple therapy (TT; ICS+ LABA+
LAMA) may differ from the current GOLD treatment recommendations. This study identified …

Purpose Treatment guidance for chronic obstructive pulmonary disease (COPD)
recommends inhaled corticosteroid (ICS)+ long-acting muscarinic antagonist+ long-acting …

Introduction Maintenance treatment strategies in COPD recommend inhaled corticosteroid
(ICS)+ long-acting muscarinic antagonist (LAMA)+ long-acting β 2-agonist (LABA) triple …

Background Real-world prescription pathways leading to triple therapy (TT)(inhaled
corticosteroid [ICS] plus long-acting β2-agonist bronchodilator [LABA] plus long-acting …

Factors predicting prescriptions of triple therapy were investigated in a large group of
general practitioners in Italy. In the population treated by identified general practitioners, a …

Purpose Inhaled triple therapy is recommended for patients with chronic obstructive
pulmonary disease (COPD) who have poorly controlled symptoms and to reduce the risk of …

Background The combination of two long acting bronchodilators with an inhaled
corticosteroid, known as Triple Therapy (TT), is a usual clinical practice for patients affected …

Background: Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines
recommend triple therapy (TT) for chronic obstructive pulmonary disease (COPD) patients …